tetano
Editor, Senior Moderator
Influenza Other Respir Viruses
. 2025 Aug;19(8):e70150.
doi: 10.1111/irv.70150. Incidence Rates of RSV-Associated Hospitalizations Among Adults in Middle Tennessee, United States, October 2022 Through September 2023
Carlos G Grijalva[SUP] 1 [/SUP], Jesse O Wrenn[SUP] 1 [/SUP], Jonathan E Schmitz[SUP] 1 [/SUP], Karen F Miller[SUP] 1 [/SUP], Adrienne Baughman[SUP] 1 [/SUP], Ian D Jones[SUP] 1 [/SUP], James D Chappell[SUP] 1 [/SUP], Natasha B Halasa[SUP] 1 [/SUP], Paul W Blair[SUP] 1 [/SUP], Yuwei Zhu[SUP] 1 [/SUP], H Keipp Talbot[SUP] 1 [/SUP], Jonathan D Casey[SUP] 1 [/SUP], Fatimah S Dawood[SUP] 2 [/SUP], Diya Surie[SUP] 2 [/SUP], Wesley H Self[SUP] 1 [/SUP]; Investigating Respiratory Viruses in the Acutely Ill (IVY) Network
Affiliations
We estimated the burden of RSV-associated hospitalizations in US adults 1 year prior to RSV vaccine introduction. The overall annual incidence rate of RSV-associated hospitalization was 31.47 (95% CI: 21.89-43.97) per 100,000 adults. Rates were 10-fold and 17-fold higher among adults 60 to 74 years and ≥ 75 years compared with adults 18 to 49 years old. This prospective assessment demonstrated the burden of RSV-associated hospitalizations among adults, with the highest hospitalization rates among adults ≥ 60 years old, in the year prior to RSV vaccine introduction.
Keywords: adults; hospitalization; rates; respiratory syncytial virus.
. 2025 Aug;19(8):e70150.
doi: 10.1111/irv.70150. Incidence Rates of RSV-Associated Hospitalizations Among Adults in Middle Tennessee, United States, October 2022 Through September 2023
Carlos G Grijalva[SUP] 1 [/SUP], Jesse O Wrenn[SUP] 1 [/SUP], Jonathan E Schmitz[SUP] 1 [/SUP], Karen F Miller[SUP] 1 [/SUP], Adrienne Baughman[SUP] 1 [/SUP], Ian D Jones[SUP] 1 [/SUP], James D Chappell[SUP] 1 [/SUP], Natasha B Halasa[SUP] 1 [/SUP], Paul W Blair[SUP] 1 [/SUP], Yuwei Zhu[SUP] 1 [/SUP], H Keipp Talbot[SUP] 1 [/SUP], Jonathan D Casey[SUP] 1 [/SUP], Fatimah S Dawood[SUP] 2 [/SUP], Diya Surie[SUP] 2 [/SUP], Wesley H Self[SUP] 1 [/SUP]; Investigating Respiratory Viruses in the Acutely Ill (IVY) Network
Affiliations
- PMID: 41247261
- DOI: 10.1111/irv.70150
We estimated the burden of RSV-associated hospitalizations in US adults 1 year prior to RSV vaccine introduction. The overall annual incidence rate of RSV-associated hospitalization was 31.47 (95% CI: 21.89-43.97) per 100,000 adults. Rates were 10-fold and 17-fold higher among adults 60 to 74 years and ≥ 75 years compared with adults 18 to 49 years old. This prospective assessment demonstrated the burden of RSV-associated hospitalizations among adults, with the highest hospitalization rates among adults ≥ 60 years old, in the year prior to RSV vaccine introduction.
Keywords: adults; hospitalization; rates; respiratory syncytial virus.